First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Peinemann, Frank ^a   Grouven, Ulrich ^a,b   Kröger, Nicolaus ^c   Bartel, Carmen ^a   Pittler, Max H ^d   Lange, Stefan ^a  

^a INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

AGE DISTRIBUTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; DISEASE SEVERITY; DONOR SELECTION; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT DURATION; ADOLESCENT; ADULT; AGED; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DONOR; FEMALE; HISTOCOMPATIBILITY TEST; MALE; MIDDLE AGED; PUBLISHING; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PUBLICATION BIAS; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955568157     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018572     Document Type: Article

References (78)

1. ORD, (2010) Office of Rare Diseases Terms: Aplastic anemia Bethesda National Institutes of Health (NIH).
2. Kaufman DW, Kelly JP, Issaragrisil S, Laporte JR, Anderson T, et al. (2006) Relative incidence of agranulocytosis and aplastic anemia. Am J Hematol 81: 65-67.
3. Brodsky RA, Jones RJ, (2005) Aplastic anaemia. Lancet 365: 1647-1656.
4. Young NS, Calado RT, Scheinberg P, (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108: 2509-2519.
5. EBMT-AAWP (2000) Guidelines for treating of aplastic anemia London European Group for Blood and Marrow Transplantation (EBMT) Aplastic Anaemia Working Party (AAWP).
6. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, et al. (2006) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Definitions and current practice in Europe. Bone Marrow Transplant 37: 439-449.
7. Marsh J, (2006) Making therapeutic decisions in adults with aplastic anemia. Hematology Am Soc Hematol Educ Program pp. 78-85.
8. Guinan EC, (2009) Acquired aplastic anemia in childhood. Hematol Oncol Clin North Am 23: 171-191.
9. Marsh JCW, Ball SE, Cavenagh J, Darbyshire P, Dokal I, et al. (2009) Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147: 43-70.
10. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
11. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6: e1000100.
12. Cochrane (2005) Glossary of Terms (Version 4.2.5) Oxford The Cochrane Collaboration.
13. MeSH (2006) MeSH Tree Number Changes- 2007 MeSH. September 14, 2006. Bone Marrorw Transplantation, deleted MN: E4.936.225.687.155 Bethesda National Library of Medicine (NLM).
14. Tybaert S, (2007) MeSH Data Changes- 2008. NLM Tech Bull 359 pp. e6.
15. Armand P, Antin JH, (2007) Allogeneic stem cell transplantation for aplastic anemia. Biol Blood Marrow Transplant 13: 505-516.
16. Bacigalupo A, (2008) Treatment strategies for patients with severe aplastic anemia. Bone Marrow Transplant 42 (Suppl 1): S42-S44.
17. Davies JK, Guinan EC, (2007) An update on the management of severe idiopathic aplastic anaemia in children. Br J Haematol 136: 549-564.
18. ASH (2010) Bloodjournal of the American Society of Hematology, ASH Annual Meeting Abstracts: search terms = aplastic + anemia + transplantation Washington American Society of Hematology (ASH).
19. ClinicalTrials (2010) Clinical Trials: search terms = aplastic + anemia + transplantation Bethesda National Institutes of Health (NIH).
20. Schrezenmeier H, Bacigalupo A, Aglietta M, Frickhofen N, Führer M, et al. (2000) Guidelines for Treatment of Aplastic Anemia. Consensus Document of a group of interntional experts. In: Schrezenmeier H, Bacigalupo A, editors. Aplastic Anemia Pathophysiology and Treatment Cambridge Cambridge University Press pp. 308-315.
21. Cochrane (2009) Section 13.5. Assessing risk of bias in non-randomized studies. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 502 [updated September 2009] Oxford The Cochrane Collaboration.
22. Parmar MK, Torri V, Stewart L, (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815-2834.
23. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR, (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8: 16.
24. Cochrane (2009) Section 9.4.3 A generic inverse-variance approach to meta-analysis. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 502 [updated September 2009] Oxford The Cochrane Collaboration.
25. Cochrane (2009) Section 7.7.7 Data extraction for estimates of effects. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 502 [updated September 2009] Oxford The Cochrane Collaboration.
26. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
27. Higgins JPT, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
28. Cochrane (2009) Section 13.6.2.4 When pooling is judged not to be appropriate. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 502 [updated September 2009] Oxford The Cochrane Collaboration.
29. Cochrane (2009) Section 9.5.2 Identifying and measuring heterogeneity. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 502 [updated September 2009] Oxford The Cochrane Collaboration.
30. Thompson SG, Higgins JP, (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573.
31. Ahn MJ, Choi JH, Lee YY, Choi IY, Kim IS, et al. (2003) Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial. Int J Hematol 78: 133-138.
32. Arranz R, Otero MJ, Ramos R, Steegmann JL, Lamana ML, et al. (1994) Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy. Bone Marrow Transplant 13: 383-387.
33. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, et al. (1988) Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol 70: 177-182.
34. Bacigalupo A, Brand R, Oneto R, Bruno B, Socie G, et al. (2000) Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy-The European Group for Blood and Marrow Transplantation experience. Semin Hematol 37: 69-80.
35. Bayever E, Champlin R, Ho W, Lenarsky C, Storch S, et al. (1984) Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. J Pediatr 105: 920-925.
36. Champlin R, Ho W, Bayever E, Winston DJ, Lenarsky C, et al. (1984) Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody. Prog Clin Biol Res 148: 227-238.
37. De Planque MM, Richel DJ, Fibbe WE, den Ottolander GJ, Guiot HF, et al. (1990) Acquired severe aplastic anaemia in adults-a single centre study with 13 years follow-up. Neth J Med 37: 103-110.
38. Doney K, Leisenring W, Storb R, Appelbaum FR, (1997) Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team. Ann Intern Med 126: 107-115.
39. Fouladi M, Herman R, Rolland-Grinton M, Jones-Wallace D, Blanchette V, et al. (2000) Improved survival in severe acquired aplastic anemia of childhood. Bone Marrow Transplant 26: 1149-1156.
40. Führer M, Burdach S, Ebell W, Gadner H, Haas R, et al. (1998) Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Klin Padiatr 210: 173-179.
41. Führer M, Rampf U, Baumann I, Faldum A, Niemeyer C, et al. (2005) Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 106: 2102-2104.
42. Ghavamzadeh A, Iravani M, Vafaiezadeh F, Jahani M, Mousavi A, (2004) Bone marrow transplantation versus immunosuppressive therapy in severe aplastic anemia, 1990-2001. Arch Iran Med 7: 272-278.
43. Gillio AP, Boulad F, Small TN, Kernan NA, Reyes B, et al. (1997) Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation. Biol Blood Marrow Transplant 3: 18-24.
44. Gluckman E, Devergie A, Faille A, Bussel A, Benbunan M, et al. (1979) Antilymphocyte globulin treatment in severe aplastic anemia-comparison with bone marrow transplantation. Report of 60 cases. Haematol Blood Transfus 24: 171-179.
45. Halperin DS, Grisaru D, Freedman MH, Saunders EF, (1989) Severe acquired aplastic anemia in children: 11-year experience with bone marrow transplantation and immunosuppressive therapy. Am J Pediatr Hematol Oncol 11: 304-309.
46. Kahn Q, Ellis RJ, Skikne BS, Mayo MS, Allgood JW, et al. (2002) A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution. Military Medicine pp. 541-545.
47. Kim I, Yoon SS, Park S, Kim BK, Kim NK, (2003) The treatment of severe aplastic anemia: outcomes of bone marrow transplantation and immunosuppressive therapy in a single institution of Korea. J Korean Med Sci 18: 365-371.
48. Kojima S, Horibe K, Inaba J, Yoshimi A, Takahashi Y, et al. (2000) Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol 111: 321-328.
49. Lawlor ER, Anderson RA, Davis JH, Fryer CJ, Pritchard SL, et al. (1997) Immunosuppressive therapy: a potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood? J Pediatr Hematol Oncol 19: 115-123.
50. Locasciulli A, van't Veer L, Bacigalupo A, Hows J, Van Lint MT, et al. (1990) Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party. Bone Marrow Transplant 6: 211-217.
51. Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, et al. (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 92: 11-18.
52. Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, et al. (1995) Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood 85: 283-290.
53. Pitcher LA, Hann IM, Evans JP, Veys P, Chessells JM, et al. (1999) Improved prognosis for acquired aplastic anaemia. Arch Dis Child 80: 158-162.
54. Tzeng CH, Chen PM, Chuang MW, Liu JH, Hsieh RK, et al. (1989) Treatment of severe aplastic anemia: comparison of bone marrow transplantation to immunotherapy. Chung Hua I Hsueh Tsa Chih 43: 21-28.
55. Viollier R, Passweg J, Gregor M, Favre G, Kühne T, et al. (2005) Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia. Ann Hematol 84: 47-55.
56. Werner EJ, Stout RD, Valdez LP, Harris RE, (1989) Immunosuppressive therapy versus bone marrow transplantation for children with aplastic anemia. Pediatrics 83: 61-65.
57. Gray R, Wheatley K, (1991) How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant 7 (Suppl 3): 9-12.
58. Wheatley K, Gray R, (2004) Commentary: Mendelian randomization-an update on its use to evaluate allogeneic stem cell transplantation in leukaemia. Int J Epidemiol 33: 15-17.
59. Ljungman P, Bregni M, Brune M, Cornelissen J, Witte TD, et al. (2009) Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant.
60. Gafter-Gvili A, Ram R, Gurion R, Paul M, Yeshurun M, et al. (2008) ATG plus cyclosporine reduces all-cause mortality in patients with severe aplastic anemia-systematic review and meta-analysis. Acta Haematol 120: 237-243.
61. Linden T, Gerss J, Jürgens H, (2007) The crux of the log rank test. Haematologica 92: e122.
62. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG, (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291: 2457-2465.
63. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, et al. (2010) The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 340: c365.
64. Song F, Eastwood AJ, Gilbody S, Duley L, Sutton AJ, (2000) Publication and related biases. Health Technol Assess 4: 1-115.
65. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, et al. (1997) Language bias in randomised controlled trials published in English and German. Lancet 350: 326-329.
66. Jüni P, Holenstein F, Sterne J, Bartlett C, Egger M, (2002) Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 31: 115-123.
67. Moher D, Pham B, Lawson ML, Klassen TP, (2003) The inclusion of reports of randomised trials published in languages other than English in systematic reviews. Health Technol Assess 7: 1-90.
68. Galandi D, Schwarzer G, Antes G, (2006) The demise of the randomised controlled trial: bibliometric study of the German-language health care literature, 1948 to 2004. BMC Med Res Methodol 6: 30.
69. Webb DK, Hann IM, Chessells JM, (1991) Acquired aplastic anaemia: still a serious disease. Arch Dis Child 66: 858-861.
70. Nissen C, Tichelli A, Gratwohl A, Warthmann C, Moser Y, et al. (1999) High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia-A possible role of high endogenous IL-2 in their suppression. Acta Haematol 101: 165-172.
71. Speck R, Tichelli A, Gratwohl A, Nissen C, (1994) Treatment of severe aplastic anemia: A longterm followup of 175 patients on antilymphocyte globulin or bone marrow transplantation. Chin Med J 107: 739.
72. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B, (1988) Late haematological complications in severe aplastic anaemia. Br J Haematol 69: 413-418.
73. Speck B, Gratwohl A, Nissen C, Osterwalder B, Wursch A, et al. (1986) Treatment of severe aplastic anemia. Exp Hematol 14: 126-132.
74. Speck B, Gratwohl A, Nissen C, Osterwalder B, Signer E, et al. (1984) Treatment of severe aplastic anemia: a prospective study of antilymphocyte globulin versus bone marrow transplantation. Prog Clin Biol Res 148: 249-258.
75. Speck B, Gratwohl A, Nissen C, Osterwalder B, Signer E, et al. (1983) Bone marrow graft versus ALG in patients with aplastic anaemia. Biomed Pharmacother 37: 139-143.
76. Speck B, Gratwohl A, Nissen C, Leibundgut U, Ruggero D, et al. (1981) Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation. Br Med J 282: 860-863.
77. Speck B, Gratwohl A, Nissen C, (1980) Severe aplastic anemia: A prospective study on the value of different therapeutic approaches in 37 successive patients. Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, 13-16 April 1980. Blut 41: 160-163.
78. Speck B, Gluckman E, Haak HL, van Rood JJ, (1977) Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet 2: 1145-1148.